|
Sudeep Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
6623.87 Cr.
|
P/BV
|
9.13
|
Book Value (Rs.)
|
64.26
|
|
52 Week High/Low (Rs.)
|
795/544
|
FV/ML
|
1/1
|
P/E(X)
|
47.76
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 1.00 | 10.00 | 10.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 497.41 | 454.67 | 426.17 |
| Other Operating Revenues | 4.59 | 4.62 | 2.57 |
| Total Operating Revenues | 502.00 | 459.28 | 428.74 |
| | | | |
| Other Income | 9.33 | 6.10 | 9.52 |
| Total Revenue | 511.33 | 465.38 | 438.26 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 208.63 | 153.74 | 200.15 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -43.84 | 11.57 | -17.68 |
| Employee Benefit Expenses | 38.34 | 29.41 | 66.10 |
| Finance Costs | 5.85 | 3.92 | 4.74 |
| Depreciation And Amortisation Expenses | 10.59 | 9.01 | 7.92 |
| Other Expenses | 108.92 | 82.91 | 91.05 |
| Total Expenses | 328.48 | 290.56 | 352.28 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 182.85 | 174.82 | 85.98 |
| | | | |
| Profit/Loss Before Tax | 182.85 | 174.82 | 85.98 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 43.65 | 40.48 | 23.46 |
| Deferred Tax | 0.50 | 1.15 | 0.20 |
| Total Tax Expenses | 44.15 | 41.63 | 23.66 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 138.69 | 133.19 | 62.32 |
| | | | |
| Profit/Loss From Continuing Operations | 138.69 | 133.19 | 62.32 |
| | | | |
| Profit/Loss For The Period | 138.69 | 133.19 | 62.32 |
| Consolidated Profit/Loss After MI And Associates | 138.69 | 133.19 | 62.32 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 12.78 | 12.28 | 5.74 |
| Diluted EPS (Rs.) | 12.78 | 12.28 | 5.74 |
